
IFIM Projects
From Data to Shared Value – Legal Frameworks and Contract Models for AI Partnerships in Healthcare
Led by IFIM at Stockholm University in collaboration with Region Stockholm and Karolinska University Hospital, this research project explores how legal frameworks and contractual models can support responsible AI innovation in healthcare. The project focuses on data governance, intellectual property rights and fair benefit-sharing, aiming to develop practical solutions that promote transparent and sustainable partnerships between healthcare institutions, universities and industry.
About the Project
From Data to Shared Value – Legal Frameworks and Contract Models for AI Partnerships in Healthcare
Research project 2026–2028
Artificial intelligence is transforming healthcare, creating new possibilities for medical research, improved diagnostics, personalised treatments and more effective patient care. Much of this development relies on access to clinical data generated and maintained by hospitals and other publicly funded healthcare institutions. As collaborations between healthcare providers, universities and private companies become increasingly important, they also raise fundamental legal questions about who controls the data, who owns the resulting innovations and how the benefits of AI-driven medical advances should be distributed.
From Data to Shared Value – Legal Frameworks and Contract Models for AI Partnerships in Healthcare is a research project at IFIM – the Institute for Intellectual Property and Market Law at Stockholm University, conducted in collaboration with Region Stockholm and Karolinska University Hospital. The project examines how legal frameworks and contractual arrangements can support responsible AI innovation while ensuring that public healthcare institutions and, ultimately, society receive a fair share of the value created through the use of clinical data.
A central question concerns the relationship between access to healthcare data and the ownership of innovations developed using that data. Hospitals provide essential clinical resources, expertise and infrastructure for AI development, yet existing legal and contractual arrangements do not necessarily ensure that the resulting benefits are shared with the healthcare institutions involved. These questions are particularly relevant in Sweden, where the professors’ privilege (lärarundantaget) allows university researchers to retain rights to their inventions, potentially creating additional complexities when research is conducted in collaboration with hospitals and commercial partners.
The project explores these challenges at the intersection of intellectual property law, contract law and healthcare regulation. Particular attention is given to the interaction between Swedish law and emerging European regulatory frameworks, including the General Data Protection Regulation (GDPR), the EU Artificial Intelligence Act and the European Health Data Space (EHDS). Together, these legal frameworks shape the conditions under which clinical data can be accessed and used, how AI technologies can be developed and implemented, and how responsibilities and benefits can be allocated among the participating actors.
Combining doctrinal and comparative legal research with empirical investigations of existing agreements and collaboration practices, the project examines different approaches to data governance, intellectual property ownership, licensing and benefit-sharing. An important ambition is to move beyond identifying legal obstacles and instead develop practical contractual solutions that facilitate cooperation between healthcare institutions, universities and industry. These may include arrangements for shared ownership, preferential access to AI technologies developed using clinical data, licensing structures and revenue-sharing mechanisms.
The project also addresses the broader relationship between commercialisation, open science and the public interest. As healthcare data increasingly contributes to the development of commercially valuable AI technologies, it becomes important to consider not only how innovation can be encouraged, but also how the resulting knowledge, technologies and economic benefits can contribute to improvements in publicly funded healthcare.
The research is led by Professor Frantzeska Papadopoulou Skarp, together with doctoral researcher Leonidas Fotiadis, at Stockholm University. Through its collaboration with Region Stockholm and Karolinska University Hospital, the project connects legal research with the practical challenges faced by healthcare institutions engaging in AI development and research partnerships.
The ambition is to develop legal and contractual models that promote fair, transparent and sustainable collaborations in healthcare AI. The project is expected to result in practical contractual guidelines, governance models and policy recommendations that can support Region Stockholm and provide a basis for similar initiatives in Sweden and internationally.
By examining how clinical data can be transformed into shared value, the project contributes to IFIM’s broader research on the role of intellectual property law in innovation, digital transformation and the governance of emerging technologies.
